Communicating Benefit–Risk Decisions by US FDA, EMA, TGA, and Health Canada
, Sam Salek2 and Stuart Walker3 (1) Centre of Regulatory Excellence, Duke-NUS Graduate Medical School, Singapore, Singapore (2) Department of Pharmacy, University of Hertfordshire, Hatfield, UK (3) Centre for Innovation in Regulatory…